Healthpeak Properties, Inc. (NYSE:DOC) Shares Bought by Natixis

Natixis increased its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 6.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 326,032 shares of the real estate investment trust’s stock after acquiring an additional 18,533 shares during the quarter. Natixis’ holdings in Healthpeak Properties were worth $6,609,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of DOC. Mizuho Bank Ltd. acquired a new stake in Healthpeak Properties during the 4th quarter worth about $28,000. Harvest Fund Management Co. Ltd purchased a new position in shares of Healthpeak Properties in the fourth quarter worth approximately $30,000. Covestor Ltd raised its holdings in shares of Healthpeak Properties by 173.8% during the fourth quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust’s stock valued at $37,000 after acquiring an additional 1,152 shares during the period. AdvisorNet Financial Inc lifted its position in shares of Healthpeak Properties by 34.5% in the 4th quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock valued at $44,000 after acquiring an additional 563 shares in the last quarter. Finally, Kestra Investment Management LLC acquired a new position in Healthpeak Properties in the 4th quarter worth approximately $45,000. 93.57% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. StockNews.com lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Monday, April 14th. Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective for the company in a research report on Wednesday, January 15th. Robert W. Baird dropped their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Tuesday, February 11th. Scotiabank reduced their price target on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research report on Friday, February 28th. Finally, Wedbush reaffirmed an “outperform” rating and set a $24.00 price objective on shares of Healthpeak Properties in a research report on Friday, April 11th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $23.83.

Healthpeak Properties Trading Up 0.9 %

Healthpeak Properties stock opened at $18.75 on Monday. Healthpeak Properties, Inc. has a one year low of $17.33 and a one year high of $23.26. The company’s fifty day moving average price is $19.68 and its two-hundred day moving average price is $20.67. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The company has a market capitalization of $13.11 billion, a price-to-earnings ratio of 53.56, a PEG ratio of 2.17 and a beta of 1.02.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Friday, April 18th will be issued a dividend of $0.1017 per share. This represents a dividend yield of 6.5%. The ex-dividend date of this dividend is Thursday, April 17th. Healthpeak Properties’s dividend payout ratio is 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.